Statins reduce the toxin of preeclampsia soluble Flt1, and quench endothelial dysfunction in primary human tissues: a potential therapeutic for preeclampsia (#337)
5:00 PM
Placental Slc13a4 sulphate transporter is linked to fetal abnormalities and death. (#338)
5:00 PM
Sexual dimorphism at midgestation: recapitulation of hallmarks of growth restriction in normal female fetuses (#339)
5:00 PM
Vaginal Ureaplasma spp. colonisation correlates with elevated maternal anti-Ureaplasma antibody responses in early pregnancy (#340)
5:00 PM
The newly described primate and placental specific sFlt1 isoform - e15a is biologically active and antagonises VEGF (#341)
5:00 PM
Elevated galectin-7 is predictive of miscarriage and preelampsia and detrimental to trophoblast function during implantation and placentation. (#342)
5:00 PM
The expression of Placental Glypican Proteoglycan is decreased in human idiopathic Fetal Growth Restriction. (#343)
5:00 PM
A role for hexosamine signalling in metabolic programming of adult disease? (#344)
5:00 PM
The potential role of a placenta-specific serine protease in early-onset preeclampsia (#345)
5:00 PM
The potential utility of serum HtrA3 for early detection of preeclampsia and intra-uterine growth restriction (#346)
5:00 PM
Changes in circadian expression of hepatic and adiposal clock genes during maternal adaptation to pregnancy in the mouse (#347)
5:00 PM